Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies
- PMID: 20696318
- DOI: 10.1016/S0079-6123(10)83007-9
Role of post-translational modifications in modulating the structure, function and toxicity of alpha-synuclein: implications for Parkinson's disease pathogenesis and therapies
Abstract
A better understanding of the molecular and cellular determinants that influence the pathology of Parkinson's disease (PD) is essential for developing effective diagnostic, preventative and therapeutic strategies to treat this devastating disease. A number of post-translational modifications to alpha-syn are present within the Lewy bodies in the brains of affected patients and transgenic models of PD and related disorders. However, whether disease-associated alpha-syn post-translational modifications promote or inhibit alpha-syn aggregation and neurotoxicity in vivo remains unknown. Herein, we summarize and discuss the major disease-associated post-translational modifications (phosphorylation, truncation and ubiquitination) and present our current understanding of the effect of these modifications on alpha-syn aggregation and toxicity. Elucidating the molecular mechanisms underlying post-translation modifications of alpha-syn and the consequences of such modifications on the biochemical, structural, aggregation and toxic properties of the protein is essential for unravelling the molecular basis of its function(s) in health and disease. Furthermore, the identification of the natural enzymes involved in regulating the post-translational modifications of alpha-synuclein will yield novel and more tractable therapeutic targets to treat PD and related synucleinopathies.
2010 Elsevier B.V. All rights reserved.
Similar articles
-
α-Synuclein aggregation and modulating factors.Subcell Biochem. 2012;65:109-64. doi: 10.1007/978-94-007-5416-4_6. Subcell Biochem. 2012. PMID: 23225002 Review.
-
Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.Neuron. 2006 Oct 5;52(1):33-8. doi: 10.1016/j.neuron.2006.09.026. Neuron. 2006. PMID: 17015225 Review.
-
Aggregation of alpha-synuclein in the pathogenesis of Parkinson's disease.J Neurol. 2003 Oct;250 Suppl 3:III11-4. doi: 10.1007/s00415-003-1303-x. J Neurol. 2003. PMID: 14579119
-
The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.J Neurochem. 2009 Jul;110(1):208-19. doi: 10.1111/j.1471-4159.2009.06124.x. Epub 2009 Apr 27. J Neurochem. 2009. PMID: 19457126
-
alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.Proc Natl Acad Sci U S A. 2002 Aug 6;99(16):10813-8. doi: 10.1073/pnas.152339799. Epub 2002 Jul 16. Proc Natl Acad Sci U S A. 2002. PMID: 12122208 Free PMC article.
Cited by
-
Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications.Biomolecules. 2015 Jun 25;5(3):1210-27. doi: 10.3390/biom5031210. Biomolecules. 2015. PMID: 26120904 Free PMC article. Review.
-
Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.Hum Mol Genet. 2020 May 8;29(7):1180-1191. doi: 10.1093/hmg/ddaa039. Hum Mol Genet. 2020. PMID: 32160287 Free PMC article.
-
Combining non-canonical amino acid mutagenesis and native chemical ligation for multiply modifying proteins: A case study of α-synuclein post-translational modifications.Methods. 2023 Oct;218:101-109. doi: 10.1016/j.ymeth.2023.08.002. Epub 2023 Aug 6. Methods. 2023. PMID: 37549799 Free PMC article.
-
Intracellular repair of oxidation-damaged α-synuclein fails to target C-terminal modification sites.Nat Commun. 2016 Jan 25;7:10251. doi: 10.1038/ncomms10251. Nat Commun. 2016. PMID: 26807843 Free PMC article.
-
Lysine acylation in superoxide dismutase-1 electrostatically inhibits formation of fibrils with prion-like seeding.J Biol Chem. 2017 Nov 24;292(47):19366-19380. doi: 10.1074/jbc.M117.805283. Epub 2017 Oct 3. J Biol Chem. 2017. PMID: 28974578 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous